ArticleAnnals of surgery open : perspectives of surgical history, education, and clinical approaches2025
Impact of COVID-19 on Opioid Prescribing, Consumption, Pain, and Outcomes after Surgery.
Article in Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim is to compare opioid prescription, consumption, and patient-reported and clinical outcomes after surgical discharge pre- versus post-COVID-19 pandemic. Background: Numerous studies have demonstrated negative health outcomes after pandemic onset. However, the impact on postoperative opioid use, pain, and relevant outcomes is unclear. Methods: Using interrupted time series analysis, we examined opioid-naive adults undergoing a variety of surgical procedures across 69 hospitals in a statewide quality collaborative, adjusting for demographic and clinical factors. We compared postsurgical outcomes in the prepandemic period (June 1, 2018-February 29, 2020) and the postpandemic period (June 1, 2020-December 31, 2021). Primary outcomes included 30-day opioid prescriptions and patient-reported consumption; secondary outcomes included patient-reported pain, quality of life, satisfaction, and surgical regret; and the composite outcome included 30-day complications, readmissions, and emergency department visits. Results: The primary analysis included 18,031 patients in the prepandemic group and 19,973 in the postpandemic group. Adjusted analyses showed no significant impact of the pandemic on opioid prescribing (level change in any prescription: -0.012 [95% confidence interval (CI): -0.073 to 0.048]; number of pills prescribed: 0.863 [95% CI: -0.277 to 2.003]) or opioid consumption (level change in amount consumed: 0.614 [95% CI: -11.748 to 12.977]). No differences appeared in patient-reported outcomes or composite outcomes of 30-day complications, readmissions, and emergency room visits ( Conclusions: The absence of significant changes in opioid prescribing or consumption, clinical outcomes, and patient-reported outcomes suggest that certain quality improvement outcomes may have been resilient to disruptions caused by the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.